Skip to content

A study to assess the feasibility of local microcirculation monitoring and management in evaluating effect of regional anesthesia

A study to assess the feasibility of local microcirculation monitoring and management in evaluating effect of regional anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16008520
Enrollment
Unknown
Registered
2016-05-23
Start date
2016-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

regional anesthesia or nerve blokade of orthopaedic surgery

Interventions

Gold Standard:
Index test:

Sponsors

Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. hospitalized patients of Age 18-80 years (including 18, 80) , male or female, voluntary participation, ASA grade 1-3 level, BMI18.5-30, and above weigh of 45kg; 2. patients with lower limb orthopedic surgery (including knee replacement, hip replacement surgery, arthroscopic knee surgery, etc.); 3. patients of nerve block anesthesia; 4. patients who are able to understand the pain intensity rating method, and adequate informed and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. local anesthesia contraindications (allergy to local anesthetic, local inflammation); 2. patients with mental, neurological diseases, and paitents who can not express their wishes; 3. arteriovenous fistula, patients with vascular disease (diabetes, rheumatoid arthritis, etc.); 4. patients with sepsis; 5. Pregnant or breast-feeding patients; 6. patients with high risk of bleeding, coagulation abnormalities, congenital bleeding disorders (such as hemophilia), thrombocytopenia, and platelet function disorder; 7. patients with severe heart failure, hypertension (blood pressure SBP>=160mmHg or DBP>=100mmHg)and hypotension (SBP<=90mmHg or DBP<=60mmHg).

Design outcomes

Primary

MeasureTime frame
Tissue oxygen saturation;

Secondary

MeasureTime frame
temperature;

Countries

China

Contacts

Public ContactChangsheng Huang

Xiangya Hospital, Central South University

docthuang2005@hotmail.com+86 15974172150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026